MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-02-0023067
Maithri Drugs Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹131.9 Cr
▲ 14% YoY
Net profit · FY 2024
₹7.59 Cr
Net margin 5.8%
EBITDA · FY 2024
₹20.86 Cr
EBITDA margin 15.8%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹87.55 Cr
Satisfied ₹13.28 Cr
Company age
13 yrs
Est. 2013
Employees · EPFO
570
Provident fund records
About Maithri Drugs Private Limited
Data last updated:
Maithri Drugs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 18 February 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2013PTC085821. Its GSTIN is 36AAICM4285G1Z8 (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Naga Vikas Chakilam and Naga Raju Chakilam.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹131.9 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹7.59 Cr (net margin 5.8%) and EBITDA of ₹20.86 Cr (EBITDA margin 15.8%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 14% over five years.
The company has about 570 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Maithri Drugs. As per MCA filings, the company has open charges of ₹87.55 Cr and satisfied charges of ₹13.28 Cr on record. Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it; 1 case is pending. The company has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in July 2016. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Kinvan Private Limited with revenue of ₹135.98 Cr.
Maithri Drugs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0023067). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website maithridrugs.com.
Company details
CIN U24100TG2013PTC085821
Registration Number 085821
Incorporation Date 18 February 2013
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0023067
CIN history
Maithri Drugs has one previous CIN (Corporate Identification Number): U24100AP2013PTC085821. The current CIN is U24100TG2013PTC085821, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2013PTC085821 | Current |
| U24100AP2013PTC085821 | Previous |
Recognitions & Rankings of Maithri Drugs
Contact details
Maithri Drugs Private Limited's registered office is in Hyderabad, Telangana. Its website is maithridrugs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressDwaraka Signature 2nd Floor Plot No. 14D/1 Survey No. 74 And 75 Jaihind Enclave M, Adhapur, Hyderabad, Telangana, India – 500081
- IndustryPharma, API Manufacturers
To see the full contact details of Maithri Drugs Private Limited, buy the company report.
Comprehensive company report
Maithri Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Maithri Drugs operates one associated brand: Maithri Drugs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures APIs using advanced techniques for global pharmaceutical needs. | maithridrugs.com |
Business activity
The main business activity of Maithri Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Maithri Drugs Private Limited, buy the company report.
Financials of Maithri Drugs Private Limited
FY 2024 filings availableMaithri Drugs Private Limited reported revenue of ₹131.9 Cr (up 14% YoY) for FY 2024.
Revenue · FY 2024
₹131.9 Cr ▲ 14%
Net profit · FY 2024
₹7.59 Cr margin 5.8%
EBITDA · FY 2024
₹20.86 Cr margin 15.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 17%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 26%
5 years · compounded
▲ 17%
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 14% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20.86 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.59 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.8% | ||||
| Net Profit Margin | 5.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maithri Drugs Private Limited, buy the company report.
Board of directors of Maithri Drugs Private Limited
Maithri Drugs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naga Vikas Chakilam | Director | 31 Mar 2018 | 8 Years 7 Months | Current |
| Naga Raju Chakilam | Director | 18 Feb 2013 | 13 Years 8 Months | Current |
Peer comparison
Maithri Drugs Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kinvan Private Limited | ₹135.98 Cr (FY 2025) | 11959.0% | Solan, Himachal Pradesh, India | |||
| R.N. Laboratories Private Limited | ₹135.13 Cr (FY 2025) | 19.0% | Mumbai, Maharashtra, India | |||
| Alkaloids Pvt Ltd. | ₹134.62 Cr (FY 2024) | 42.0% | Hyderabad, Telangana, India | |||
| Cytobiologics Private Limited | ₹134.03 Cr (FY 2024) | 347.0% | Patancheru, Telangana, India | |||
| Maithri Drugs Private Limitedthis company | ₹131.9 Cr (FY 2024) | ₹7.59 Cr | 5.8% | 14.0% | 570 | Hyderabad, Telangana, India |
| B E C Chemicals Private Limited | ₹130.65 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India | |||
| Envee Drugs Private Limited | ₹128.76 Cr (FY 2025) | 17.0% | Nadiad, Gujarat, India | |||
| SV Plastochem Private Limited | ₹127.64 Cr (FY 2024) | Nashik, Maharashtra, India | ||||
| Chemeca Drugs Private Limited | ₹127.59 Cr (FY 2025) | 5.0% | Visakhapatnam, Andhra Pradesh, India |
To see the full peer comparison of Maithri Drugs Private Limited, buy the company report.
Auditor
Maithri Drugs Private Limited is audited by B.R.M. Reddy & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B.R.M. Reddy & Co | FY 2023 | 0003247S |
Shareholding
The shareholding of Maithri Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maithri Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹87.55 Cr
Satisfied charges
₹13.28 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 May 2025 | 101124289 | Hdfc Bank Limited | ₹15.2 Lakh | Open | |
| 07 Feb 2025 | 101082617 | Hdfc Bank Limited | ₹16.23 Lakh | Open | |
| 28 Nov 2024 | 101019799 | Others | ₹20 Cr | Open | |
| 27 Sep 2024 | 100983321 | Sidbi | ₹1.23 Cr | Open | |
| 09 Jan 2023 | 100671992 | Axis Bank Limited | ₹1.11 Cr | Open |
To see the full charge records of Maithri Drugs Private Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Maithri Drugs Private Limited has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in July 2016.
Total deals
2
Rights issue
1
Secondary share transfer
1
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2015 | Rights issue | ₹99 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Maithri Drugs Private Limited has 4 court cases on record: 2 filed by Maithri Drugs, 2 filed against it. 1 case is pending and 3 are disposed.
Total cases
4
Filed by the company
2
Filed against the company
2
Pending
1
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 2 | 1 |
Cases on record (3 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Writ petition | Filed by the company against Southern Power Distribution Company of Telangana Limited and 2 others | Pending |
| High Court for State of Telangana | Writ petition | Filed by the company against The State of Telangana | Disposed |
| High Court, TELANGANA | Writ petition | Filed against the company by an individual | Disposed |
To see the full case history of Maithri Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Maithri Drugs Private Limited was last rated by Crisil on 26 Nov 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 26 Nov 2020 |
To see the full credit ratings and regulatory alerts of Maithri Drugs Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maithri Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Maithri Drugs Private Limited has a workforce of 570 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
570
Active EPFO establishments
1
Employee growth
1.2%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 570 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Maithri Drugs Private Limited, buy the company report.
GST
Maithri Drugs has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICM4285G1Z8 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Maithri Drugs Private Limited, buy the company report.
Recent activity
Maithri Drugs Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Satyanarayana Reddy Manne ceased to be Director on 19 Jul 2021.
Charges
A charge with Others of Rs. 20.00 Cr registered on 28 Nov 2024 with Charge ID 101019799 was modified on 08 Jul 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.15 Cr with Charge ID 101124289 was registered on 05 May 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.16 Cr with Charge ID 101082617 was registered on 07 Feb 2025.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101019799 was registered on 28 Nov 2024.
AGM
Maithri Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Sidbi amounted to Rs. 1.23 Cr with Charge ID 100983321 was registered on 27 Sep 2024.
Filing
Maithri Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.11 Cr with Charge ID 100671992 was registered on 09 Jan 2023.
Charges
A charge with Axis Bank Limited of Rs. 62.15 Cr registered on 30 Jul 2020 with Charge ID 100360562 was modified on 28 Dec 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 2.75 Cr with Charge ID 100554379 was registered on 23 Mar 2022.
Ceased
Satyanarayana Reddy Manne ceased to be Director.
Charges
A charge registered on 25 Mar 2015 via Charge ID 10563285 with Yes Bank Limited was fully satisfied on 17 Nov 2020.
6 earlier events are in the company report.
Frequently asked questions
Maithri Drugs is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 18 February 2013 (13+ years old) and is registered under CIN U24100TG2013PTC085821.
Maithri Drugs has 2 current directors:
- Naga Vikas Chakilam - Director
- Naga Raju Chakilam - Director
The latest financial statements of Maithri Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Maithri Drugs is 36AAICM4285G1Z8, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Maithri Drugs is U24100TG2013PTC085821. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maithri Drugs has 4 court cases on record: 2 filed by the company and 2 filed against it. 1 is pending.
Maithri Drugs was incorporated on 18 February 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
Maithri Drugs has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in July 2016.
The peers of Maithri Drugs by revenue are Kinvan Private Limited, R.N. Laboratories Private Limited, Alkaloids Pvt Ltd, Cytobiologics Private Limited, B E C Chemicals Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Satyanarayana Reddy Manne ceased to be Director on 19 Jul 2021. Naga Vikas Chakilam was appointed as Director on 31 Mar 2018. Naga Raju Chakilam was appointed as Director on 18 Feb 2013.
Yes, Maithri Drugs is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0023067).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages